{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:25:26Z","timestamp":1765758326074},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/mjt.0b013e318262316f","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T18:16:39Z","timestamp":1348596999000},"page":"442-446","source":"Crossref","is-referenced-by-count":35,"title":["Evaluating the Completeness and Accuracy of MedWatch Data"],"prefix":"10.1097","volume":"21","author":[{"given":"Kenneth A.","family":"Getz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Stergiopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth I.","family":"Kaitin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1001\/jama.1993.03500210065033","article-title":"Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems.","volume":"269","author":"Kessler","year":"1993","journal-title":"JAMA"},{"key":"R3-2-20210202","first-page":"145","article-title":"Food and drug administration update.","volume":"36","author":"White","year":"1998","journal-title":"Clin Toxicol"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/jama.1990.03440130073028","article-title":". Physician reporting of adverse drug reactions.","volume":"263","author":"Scott","year":"1990","journal-title":"JAMA"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00002018-200730020-00004","article-title":"Potential use of data-mining algorithms for the detection of surprise adverse drug reactions.","volume":"30","author":"Hauben","year":"2007","journal-title":"Drug Safety"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00002018-200225070-00007","article-title":". Renal failure with the use of celecoxib and rofecoxib.","volume":"25","author":"Ahmad","year":"2002","journal-title":"Drug Safety"},{"key":"R9-2-20210202","first-page":"11","article-title":"Pikalov A, tran Q, et al.. Atypical antipsychotic drugs and diabetes mellitus in the ES food and drug administration adverse event database.","volume":"42","author":"Baker","year":"2009","journal-title":"Psychopharmacol Bull"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jaad.2010.05.033","article-title":". Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients.","volume":"65","author":"Kothany","year":"2011","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e318262316f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:37:15Z","timestamp":1620963435000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201411000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e318262316f","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}